Research to develop non-addictive analgesics that could potentially be used as alternatives to addictive opioid drugs such as codeine will be undertaken by UQ under an agreement with Canadian biomedical company PreveCeutical Medical Inc.
31 January 2018
Gene therapy aimed at treating diabetes and obesity is the subject of an agreement between Australian researchers and a Canadian health and wellness company.
18 July 2017
Canadian health and wellness company PreveCeutical Medical Inc. (PMI) has signed a research and option agreement with UniQuest, The University of Queensland’s main commercialisation company, to develop stabilised natural and synthetic peptides from...
21 April 2017
